Therefore, our results suggest that 14-3-3γ regulates the activity of LRRK2 by reciprocally interacting with the phosphorylation of the binding sites, thereby contributing to the pathological characteristics of PD. This evidence concerns the gene LRRK2 and Parkinson disease.